PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Brain Res. Author manuscript; available in PMC 2011 January 8.
Published in final edited form as:
PMCID: PMC2799243
NIHMSID: NIHMS152924

Anterioposterior distribution of AT1 angiotensin receptors in caudal brainstem cardiovascular regulatory centers of the rat

Abstract

Angiotensin II acts on Ang II type 1 (AT1) receptors in areas of the caudal brainstem involved in cardiovascular regulation. In particular, activation of AT1 receptors in the rostral ventrolateral medulla (RVLM) has been suggested to contribute to hypertension. However, the characteristics of AT1 receptors in the RVLM of rat, the species in which the most experimental work has been done, is not well documented. This study evaluated AT1 receptor binding along a 2.7 mm length of rat medulla, which included the full extent of the RVLM and the caudal ventrolateral medulla (CVLM). Sections of medulla from female rats cut on a cryostat were incubated with five concentrations of 125I-sarcosine1,isoleucine8 angiotensin II to assess the density (Bmax) and dissociation constant (KD) of the receptors for the radioligand. The dorsomedial medulla (DMM) displayed a high density of AT1 binding (1207±100 fmol/g), which peaked at 0.4 mm rostral to the calamus scriptorius (approximately 14 mm caudal to Bregma). The RVLM and CVLM displayed significantly lower (p < 0.01) densities of AT1 binding, 278±38 and 379±64 fmol/g, respectively. However, the dissociation constants were significantly lower (i.e., higher affinity) in RVLM and CVLM (164±38 and 178±27 pM, respectively,) than in DMM (328±12 pM, p < 0.01 and p < 0.05 respectively). These results provide an anatomical and pharmacological framework for future studies on the role in cardiovascular regulation of AT1 receptors in the caudal brainstem.

Keywords: rostral ventrolateral medulla (RVLM), caudal ventrolateral medulla (CVLM), Dorsomedial medulla, quantitative receptor autoradiography, Saturation binding assay, Maximum binding capacity (Bmax), Dissociation constant (KD)

1. Introduction

Angiotensin II (Ang II), long known for its peripheral cardiovascular effects (Kaschina and Unger, 2003; Laragh et al., 1975), is now recognized as having significant effects on the cardiovascular system via its actions in the brain (Bourassa et al., 2008; Carlson and Wyss, 2008; McKinley et al., 2003; Phillips and de Oliveira, 2008; Sved et al., 2003; Veerasingham and Raizada, 2003). Within the caudal caudal brainstem, there is evidence that Ang II acts in the dorsomedial medulla (DMM, including the nucleus of the solitary tract (NTS) and area postrema), rostral ventrolateral medulla (RVLM), and caudal ventrolateral medulla (CVLM) to regulate the cardiovascular system. The area postrema is a circumventricular organ which is reported to be sensitive to blood-borne Ang II (Bishop and Hay, 1993; Joy and Lowe, 1970). In vitro studies have shown that area postrema neurons are responsive to Ang II (Consolimcolombo et al., 1996; Hay and Lindsley, 1995; Sun and Ferguson, 1996). Injection of Ang II into the NTS region of the DMM (Diz et al., 1997; Fow et al., 1994; Katsunuma et al., 2003; Tan et al., 2005) or the CVLM (Alzamora et al., 2006; Muratani et al., 1991) decreases blood pressure whereas injection of Ang II into the RVLM increases it (Allen et al., 1988; Andreatta et al., 1988). In each instance, this action of Ang II appears to be mediated by an action on the AT1 subtype of angiotensin receptors as AT1 selective blockade abolishes these responses (Averill et al., 1994; Fontes et al., 1997; Ito et al., 2002; Tagawa and Dampney, 1999).

The actions of Ang II on caudal brainstem AT1 receptors is receiving increasing attention because of the possibility that they are major contributors to hypertension. For example, in the spontaneously hypertensive rat (SHR) model of hypertension, Ang II injection into the RVLM increases blood pressure significantly more than in the Wistar Kyoto (WKY) strain. Also, AT1 receptor blockade in the RVLM produces a significant depressor response in the SHR, but fails to produce any significant effect in the WKY (Ito et al., 2002; Muratani et al., 1991). Similar responses are also seen in the Dahl-salt sensitive rat model of hypertension (Ito et al., 2003). This suggests that activation of ventrolateral brainstem AT1 receptors contributes to hypertension in these animal models, but in normotensive animals these AT1 receptors are not tonically activated under resting conditions. In line with this, it has been shown that expression of a constitutively active AT1a receptor in the RVLM of normotensive WKY rats increased blood pressure significantly, whereas overexpression of the wild-type AT1a receptor did not (Allen et al., 2006). Heightened responsiveness of the RVLM to Ang II can even be induced in normotensive animals with an elevated salt intake (Adams et al., 2008).

Despite this increasing interest in AT1 receptors in the ventrolateral medulla (VLM), these receptors have not been adequately characterized in this region of the rat brain. Indeed, whereas autoradiographic studies of Ang II binding have provided evidence of AT1 binding sites in the VLM, the specific localization to RVLM or CVLM has not been discriminated. Two studies have attempted to quantitate the AT1 receptor binding found in the VLM; one of these studies presents data in the VLM without clearly distinguishing between RVLM and CVLM, and in fact the figure presented appears to be in a transition zone between the two (Allen et al., 1987), while the other (Song et al., 1992) describes sampling as far dorsal as the NTS.

The existing studies of Ang II binding sites in the medulla have focused on the distribution of these sites, assuming similar binding characteristics among the different regions. However, this has left open the question of whether binding affinities are the same in these different regions. The purpose of this study was to determine the density of the AT1 receptors in the RVLM, CVLM, and DMM regions of the rat using quantitative densitometric receptor autoradiography with saturation isotherm analysis to determine receptor concentration (Bmax) and dissociation constant (KD) of the receptors.

2. Results

Saturation Receptor Autoradiography

A major goal of the present study was to determine Bmax and KD of the AT1 receptor in the CVLM and RVLM of the rat caudal brainstem at different anteriorposterior coordinates with a concurrent comparison to the DMM (Figure 1). Specific AT1 binding was noted as a rostrocaudal column in the DMM region and in the VLM. AT1 Binding was also noted stretching between these two regions in the reticular formation as well as in the spinal trigeminal nucleus. For the DMM and VLM regions, at each coordinate noted, a saturation isotherm was constructed and Bmax and KD were derived. Figure 2 shows autoradiographic images of the 125I-SI Ang II saturation binding in the DMM and CVLM. Figure 3 shows autoradiographic images of 125I-SI Ang II saturation binding in the RVLM. Demonstrative saturation isotherms for the DMM, CVLM, and RVLM are shown in Figure 4. Figure 5 shows Bmax for each brain region along the anterioposterior axis.

Figure 1
Sampling Regions and Thresholding of MnA, DMM, CVLM, and RVLM
Figure 2
DMM and CVLM Saturation Binding Autoradiogram
Figure 3
RVLM Saturation Binding Autoradiogram
Figure 4
DMM, CVLM, and RVLM Saturation Isotherms
Figure 5
AT1Receptor Bmax in DMM and VLM

In the DMM, the Bmax peaks approximately 0.4 mm rostral to calamus scriptorius (>1800 fmol/g wet weight) before leveling off at approximately 1.4 mm rostral to calamus scriptorius to ~750 fmol/g wet weight. In the VLM (both caudal and rostral), the Bmax is significantly lower (p<0.001) than in the DMM averaging around 330 fmol/g wet weight. The KD did not vary along the anterioposterior axis in any of the brain regions studied (data not shown), however the KDs of the CVLM and RVLM were significantly less than that of the DMM (p<0.01), but did not significantly differ from each other. Also, the Bmax did not differ significantly between the CVLM and the RVLM. Table 1 summarizes the Bmax and KD data for the three brain regions.

Table 1
Bmax (fmol/g) and KD (pM) values (mean +/− SEM, n = 4) for DMM, CVLM, and RVLM. t values are for post hoc Bonferroni comparisons.

There was a substantial amount of 125I-SI Ang II binding in the cerebellum (Figures 2 and and3).3). However, most of this binding is not displaceable by 3 μM Ang II (Panel F of Figures 2 and and3)3) and it was not evaluated in this study.

3. Discussion

This is the first study utilizing receptor binding autoradiography to fully characterize AT1 receptor binding in the regions of the rat medulla that are critically involved in cardiovascular regulation. The key findings of this study are: (1) In addition to the previously characterized AT1 receptor binding in the DMM, AT1 receptor binding is clearly present in the rat ventrolateral medulla, extending throughout the CVLM and RVLM in the rostral-caudal plane; (2) the density of AT1 receptor binding is lower in CVLM and RVLM than in DMM; (3) the KD of AT1 binding sites is lower (i.e., higher affinity) in the ventrolateral medulla than in the DMM. Each of these issues, along with their potential physiological significance, will be discussed in turn.

3.1 Localization of AT1 binding in the rat medulla

The presence of AT1 receptors in all three of the major components of the DMM surveyed, area postrema, NTS and dorsal motor nucleus of the vagus, is well documented in previous studies (Gehlert et al., 1986; Mendelsohn et al., 1984). All three of these nuclei have cardiovascular significance: the area postrema as a sensor of blood-borne angiotensins (Joy and Lowe, 1970), the NTS as the site of termination of baroreceptor afferents (Jordan and Spyer, 1977), and the dorsal motor nucleus of the vagus as a site of preganglionic parasympathetic neurons (Taylor, 1994).

AT1 receptor binding in the RVLM region has been reported in other species (Allen et al., 1988; Mendelsohn et al., 1988; Moulik et al., 2002) and quantified in a single prior study in rat (Allen et al., 1987). However, the characterization of these receptors throughout the rostral-caudal extent of the CVLM and RVLM has not previously been reported. Based on the prior demonstration that pharmacological stimulation of AT1 receptors in the RVLM increases blood pressure (Alzamora et al., 2006; Andreatta et al., 1988; Ito et al., 2002; Sasaki and Dampney, 1990) the activity of RVLM sympathoexcitatory neurons (Allen et al., 1988; Averill et al., 1994), and neuronal excitation in vitro (Li and Guyenet, 1995), it is clear that functional AT1 receptors exist in the RVLM. Similarly, the decrease in blood pressure produced by stimulation of AT1 receptors in the CVLM provided evidence for the presence of AT1 receptors in the CVLM (Alzamora et al., 2006; Muratani et al., 1991). Based on the present data, it is clear that AT1 binding sites have a considerable rostral-caudal distribution in the ventrolateral medulla.

Although the rat has been the species most studied for the functional effects of Ang II actions in the VLM, previous receptor binding studies have not supported a robust presence of these receptors in rat VLM. Autoradiographic studies in rabbits (Mendelsohn et al., 1988; Moulik et al., 2002), sheep and humans (Allen et al., 1987) have shown that AT1 binding in the VLM is nearly as robust as in DMM. While this is not the case in the rat, the AT1 binding is still demonstrable. Immunocytochemical studies of the rat (Hu et al., 2002; Wang et al., 2008) have also suggested the presence of AT1 receptors in RVLM, but these studies are problematic for several reasons. Most importantly, the AT1 receptor antibodies utilized in those studies may not be specific to AT1 receptors, e.g. immunostaining is abundant in the inferior olivary nucleus (Hu et al., 2002) which is reported to contain only AT2 receptors (Rowe et al., 1990). Also, Western blots of immunoreactive protein isolated from kidneys of AT1a−/− mouse kidneys labeled with the antibody used by Hu et al., 2002 show identical labeling as the wild type mouse kidneys (Adams et al., 2008).

Studies using in situ hybridization histochemistry have failed to detect any significant level of AT1 receptor mRNA expression in the RVLM of the adult rat (Bunnemann et al., 1992; Lenkei et al., 1998). However, the presence of AT1 receptor mRNA in RVLM using polymerase chain reaction amplification has been reported (Adams et al., 2008; Chan et al., 2007), though the amount of AT1 receptor mRNA in the RVLM relative to other brain regions was not specified. The apparent paucity of AT1 receptor mRNA in RVLM suggests that AT1 receptors in this region may be on afferent nerve terminals. However, electrophysiological studies of RVLM neurons provides strong evidence that they are present on nerve cell bodies (Li and Guyenet, 1995). In addition, electron microscopic analysis of AT1 receptor immunoreactivity indicates that the AT1 receptors are present on dendrites of the RVLM neurons (Wang et al., 2008). Thus the question of cellular localization of AT1 receptors in the RVLM remains unresolved.

AT1 binding is present in the rostrocaudal region of the VLM, generally acknowledged to be the pressor region of the RVLM, containing spinally projecting sympathoexcitatory neurons. The sampling area used to determine AT1 binding in the RVLM encompasses the stereotaxic coordinates described for pressor sites responsive to Ang II and glutamate (Averill et al., 1994; Willette et al., 1983). The RVLM extends caudally from the caudal tip of the facial nucleus for several hundred micrometers and lies along its ventral surface. The location of AT1 binding maps well to this location (Figure 1: Panels E and F, and Figure 5). While the area with AT1 receptor binding appears to fit well with the rostrocaudal extent of the RVLM, the lateral boundaries of the AT1 receptor binding domain of the RVLM extends beyond the region where pressor responses are elicited.

The CVLM is a region that is functionally and anatomically distinct from the RVLM. Stimulation of the CVLM produces a depressor response, mediated by an inhibitory projection from CVLM to RVLM (Guyenet, 2006). AT1 receptor binding localizes to the same region of the CVLM as the depressor response that can be elicited from this region and the area containing neurons that are activated by decreased arterial pressure (Alzamora et al., 2006; Muratani et al., 1991). The density of AT1 receptor binding is rather constant along the rostral-caudal extent of this ventrolateral medullary column. However, along this column, the effect of stimulating these receptors on cardiovascular regulation is divergent. With a virtual absence of information on what controls the level of stimulation of these receptors along the extent of this column, it is difficult to try to put this into a physiological framework. Within the RVLM, the angiotensinergic input to the AT1 receptors seems to arise from the hypothalamus (Ito et al., 2002; Sved et al., 2003; Tagawa and Dampney, 1999). This input is involved in osmotically driven increases in sympathetic outflow (Freeman and Brooks, 2007), and may be involved in hypertension (Allen, 2002; Ito et al., 2002). However, there are unresolved questions regarding the existence of angiotensinergic neurons, so other sources of angiotensinergic input, e.g., extracellularly synthesized Ang II, must be considered. Similar types of studies have not examined the source of angiotensinergic influence on the CVLM. In addition to AT1 binding being present in the DMM and VLM, binding was also observed in the reticular region between the DMM and VLM (Figures 1, ,2,2, and and3),3), though with a lower density than observed even in VLM. While this pattern of localization is observed for many substances, its significance is still unclear.

3.2 AT1 receptor binding has different KD in DMM and VLM

The present studies utilizing I125SI-Ang II binding show a KD of AT1 receptors in the DMM of approximately 325 pM. This number is in reasonably good agreement with other data for AT1 receptors in brain (Rowe et al., 1992), and the saturation isotherms indicate a single high affinity site in this region. The KD measured in the ventrolateral medulla, approximately 175 pM, is still in the range of values reported in the literature, but is significantly lower than the KD that was measured in the DMM at the same time (Table 1). This lower KD suggests that neurons in the RVLM and CVLM are more sensitive to Ang II and that smaller amounts of Ang II are needed to activate these receptors. This difference in affinity presumably reflects differences in post-translational modification of the receptor or differential interaction with the membranes or protein components of the AT1 receptor-containing cells in the VLM. Whatever the explanation, it highlights potentially important differences in AT1 receptors in different brain regions.

3.3 Summary and Conclusions

The present study documents the distribution of AT1 receptor binding sites in the in rat medulla. AT1 receptors are present throughout the ventrolateral brainstem as well as in the DMM. While the density of AT1 binding sites is lower in the VLM than in the DMM, the affinity of these binding sites is greater. These observations provide anatomical information supporting the physiological role(s) of Ang II in these caudal brainstem regions in cardiovascular regulation.

4. Experimental Procedure

4.1 Subjects

Adult female retired breeder (250–300 g) Wistar rats (Harlan) were housed under standard condition with ad lib access to food and water. Rats were killed by decapitation and their brains were rapidly removed and frozen. Four adult female rats in metestrus or diestrus determined by daily microscopic evaluation of smears of vaginal epithelial cells (Long and Evans, 1922) were used for the rostrocaudal saturation binding assay. Brainstems and cerebella were serial sectioned (sets of six) with a cryostat at a thickness of 20 microns and thaw-mounted onto gelatin-coated microscope slides. The slides were air dried and kept frozen at − 20°C until used for autoradiography. The protocol for these studies was approved by the University of Mississippi IACUC. All possible efforts were made to minimize pain and discomfort to the experimental animals.

4.2 Receptor Autoradiography

Saturation angiotensin receptor autoradiography was performed essentially as previously described (Rowe et al., 1992). Briefly, slides were pre-incubated in 150 mM NaCl, 5 mM EDTA, 0.1 mM bacitracin, and 50 mM sodium phosphate buffer at pH 7.1–7.2 (AM5 buffer) for 30 minutes at room temperature. Five of the slides from each set were then incubated in AM5 buffer containing a concentration of 125I-SI Ang II ranging from 80 pM to 1900 pM in the presence of 10 μM PD123319 (a selective non-peptide AT2 receptor antagonist) for 120 minutes. Under these conditions, all specific 125I-SI Ang II binding is at the AT1 receptor (Karamyan et al., 2009). The sixth slide from each set was incubated with 1900 pM 125I-SI Ang II in the presence of an AT1 receptor saturating concentration (3 μM) of Ang II for 120 minutes to determine non-specific binding of 125I-SI Ang II. All slides were rinsed in two changes of distilled water, five changes of AM5 buffer for one minute each, and then two additional changes of distilled water. Slides were then dried under a stream of cool air, taped to cardboard, and exposed to autoradiographic film (Kodak Biomax MR-1) for either 3 (for DMM region analyses) or 10 days (for VLM analyses) at −20°C. A set of 125I calibration standards (Microscales RPA-522, Amersham) were included with each film for densitometric quantitation.

Specific binding of 125I-SI Ang II was quantitated essentially as previously described (Rowe et al., 1992). Briefly, images of the autoradiograms were analyzed using AIS 6.0 software (Interfocus Imaging, Linton, Cambridge England). Because the cerebella contained a large amount of non-specific 125I-SI Ang II binding that made it difficult to focus on the binding that was present in the caudal brainstem, only the 125I-SI Ang II binding in the caudal brainstem is shown in the saturation autoradiograms portrayed in this manuscript. The 125I calibration standards included on the autoradiograms were used to construct a standard curve relating optometric density to 125I concentration, allowing quantitation of 125I-SI Ang II binding to brain regions of interest. Non-specific binding for each of the five concentrations of 125I-SI Ang II was calculated by interpolation of a two-point linear plot of the non-specific value at 1900 pM 125I-SI Ang II and the origin. The calculated non-specific binding for each concentration of 125I-SI Ang II was then subtracted from the total binding values to derive specific binding. A thresholding technique was used during data acquisition. For the DMM, thresholding was necessary to exclude data from low-binding areas near the NTS region (see Figure 1). However, this study used multiple concentrations of 125I-SI Ang II and thus each concentration of 125I-SI Ang II required a different threshold. The level of thresholding for each concentration of 125I-SI Ang II in the DMM was determined by choosing one level of the DMM to measure (~0.8 mm rostral to calamus scriptorius), setting the threshold for one concentration of 125I-SI Ang II, and measuring the “proportional area” captured (the proportion of pixels exceeding threshold versus the total number of pixels within the area measured). The threshold was then set for other concentrations of 125I-SI Ang II (from adjacent sections) at the threshold level that produced the same “proportional area” as the first section measured. These threshold levels were then kept constant for all DMM measurements on that particular film. The same thresholding technique was used during the data acquisition for the CVLM and RVLM as well, except that the threshold was always set to zero (all pixels that measured below 0 fmol/g of binding were excluded). See Figure 1 for details.

The anteroposterior (AP) coordinates for the measurement of the RVLM were 2.3 mm rostral to 1.0 mm rostral to the calamus scriptorius (~12.1 to 13.4 mm caudal to Bregma) measured at 120 micron intervals. The approximate area measured as the RVLM was an elliptical area 0.7 mm2 in size (long axis ~1.3 mm, short axis ~ 0.7 mm), centered 2.40 mm lateral to the midline and 0.42 mm dorsal from the ventral surface (see Figure 1: Panels E and F for the placement of this sample region); the size and location of this ellipse was derived from the profile of the AT1 binding.

The anterioposterior coordinates for the measurement of the CVLM were 0.9 mm to 0.2 mm rostral to the calamus scriptorius (~13.5 to 14.2 mm caudal to Bregma) measured at 120 micron intervals. The approximate area measured as CVLM was a circular area 0.28 mm2 in size (0.6 mm in diameter) centered 2.05 mm lateral to the midline and 0.90 mm dorsal from the ventral surface. The anterioposterior coordinates for measurement of the DMM were 2.3 mm rostral to 0.4 mm caudal to the calamus scriptorius (~12.1 to 14.8 mm caudal to Bregma). The areas sampled as RVLM and CVLM encompassed the region identified as RVL (rostroventrolateral reticular nucleus) and CVL (caudoventrolateral reticular nucleus) which overlap with the areas labeled as C1 and A1 in the brain atlases of Paxinos and Watson (Paxinos and Watson, 1986; Paxinos and Watson, 2005). However, the definition of calamus scriptorius in this manuscript differs from that of Paxinos and Watson (Paxinos and Watson, 1986; Paxinos and Watson, 2005) who refer to the calamus scriptorius as obex. See Figure 1 for details.

4.3 Kinetic and Statistical Calculations

Bmax and KD for 125I-SI Ang II was determined as B=Bmax*L/(L+KD) by non-linear regression analysis (Prism, Graphpad Softward, San Diego, CA) where L= free concentration of 125I-SI Ang II and B is specific binding expressed as fmol/g wet weight of tissue.

All results are expressed as a mean ± standard error of the mean. One way Analysis of Variance (ANOVA) followed by Bonferroni post-hoc tests were used to compare values in the DMM, RVLM, and CVLM for the saturation receptor autoradiography data.

Acknowledgments

Supported by NIH grants HL-55786 and HL-076312, and The Peptide Radioiodination Service Center of the University of Mississippi.

Comprehensive List of Abbreviations

125I-SI Ang II
125I-sarcosine1,isoleucine8-Angiotensin II
Ang II
Angiotensin II
AT1
Angiotensin II type 1
Bmax
Receptor concentration
CVLM
Caudal ventrolateral medulla
DMM
Dorsomedial medulla
KD
Dissociation constant
MnA
Median accessory nucleus of the medulla
NTS
Solitary tract nucleus
RVLM
Rostral ventrolateral medulla
SHR
Spontaneously hypertensive rat
VLM
Ventrolateral medulla
WKY
Wistar-Kyoto

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • Adams JM, McCarthy JJ, Stocker SD. Excess Dietary Salt Alters Angiotensinergic Regulation of Neurons in the Rostral Ventrolateral Medulla. Hypertension. 2008;52:932–937. [PMC free article] [PubMed]
  • Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension. 2002;39:275–280. [PubMed]
  • Allen AM, Chai SY, Sexton PM, Lewis SJ, Verberne AJ, Jarrott B, Louis WJ, Clevers J, McKinley MJ, Paxinos G. Angiotensin II receptors and angiotensin converting enzyme in the medulla oblongata. Hypertension. 1987;9:III198–III205. [PubMed]
  • Allen AM, Dampney RA, Mendelsohn FA. Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am J Physiol. 1988;255:H1011–H1017. [PubMed]
  • Allen AM, Dosanjh JK, Erac M, Dassanayake S, Hannan RD, Thomas WG. Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension. 2006;47:1054–1061. [PubMed]
  • Alzamora AC, Santos RA, Campagnole-Santos MJ. Baroreflex modulation by angiotensins at the rat rostral and caudal ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1027–R1034. [PubMed]
  • Andreatta SH, Averill DB, Santos RA, Ferrario CM. The ventrolateral medulla. A new site of action of the renin-angiotensin system. Hypertension. 1988;11:I163–I166. [PubMed]
  • Averill DB, Tsuchihashi T, Khosla MC, Ferrario CM. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res. 1994;665:245–252. [PubMed]
  • Bishop VS, Hay M. Involvement of the area postrema in the regulation of sympathetic outflow to the cardiovascular system. Front Neuroendocrinol. 1993;14:57–75. [PubMed]
  • Bourassa EA, Sved AF, Speth RC. Angiotensin modulation of rostral ventrolateral medulla (RVLM) in cardiovascular regulation. Mol Cell Endocrinol 2008 [PubMed]
  • Bunnemann B, Iwai N, Metzger R, Fuxe K, Inagami T, Ganten D. The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain. Neurosci Lett. 1992;142:155–158. [PubMed]
  • Carlson SH, Wyss JM. Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action. Curr Hypertens Rep. 2008;10:233–240. [PMC free article] [PubMed]
  • Chan SH, Wang LL, Tseng HL, Chan JY. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens. 2007;25:1845–1861. [PubMed]
  • Consolimcolombo FM, Hay M, Smith TC, Elizondofournier M, Bishop VS. Subcellular mechanisms of angiotensin II and arginine vasopressin activation of area postrema neurons. Amer J Physiol-Regul Integr C. 1996;40:R34–R41. [PubMed]
  • Diz DI, Fantz DL, Benter IF, Bosch SM. Acute depressor actions of angiotensin II in the nucleus of the solitary tract are mediated by substance P. Amer. J Physiol Regul Integr C. 1997;42:R28–R34. [PubMed]
  • Fontes MA, Martins Pinge MC, Naves V, Campagnole-Santos MJ, Lopes OU, Khosla MC, Santos RA. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res. 1997;750:305–310. [PubMed]
  • Fow JE, Averill DB, Barnes KL. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol. 1994;267:H259–H266. [PubMed]
  • Freeman KL, Brooks VL. AT(1) and glutamatergic receptors in paraventricular nucleus support blood pressure during water deprivation. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1675–R1682. [PubMed]
  • Gehlert DR, Speth RC, Wamsley JK. Distribution of [125I]angiotensin II binding sites in the rat brain: a quantitative autoradiographic study. Neuroscience. 1986;18:837–856. [PubMed]
  • Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335–346. [PubMed]
  • Hay M, Lindsley KA. Membrane properties of area postrema neurons. Brain Res. 1995;705:199–208. [PubMed]
  • Hu L, Zhu DN, Yu Z, Wang JQ, Sun ZJ, Yao T. Expression of angiotensin II type 1 (AT(1)) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol. 2002;92:2153–2161. [PubMed]
  • Ito S, Hiratsuka M, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension. 2003;41:744–750. [PubMed]
  • Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension. 2002;40:552–559. [PubMed]
  • Jordan D, Spyer KM. Studies on the termination of sinus nerve afferents. Pflugers Arch. 1977;369:65–73. [PubMed]
  • Joy MD, Lowe RD. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature. 1970;228:1303–1304. [PubMed]
  • Karamyan VT, Gadepalli R, Rimoldi J, Speth R. Brain AT1 angiotensin receptor subtype binding: Importance of peptidase inhibition for identification of angiotensin II as an endogenous ligand. J Pharmacol Exp Ther 2009 [PubMed]
  • Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12:70–88. [PubMed]
  • Katsunuma N, Tsukamoto K, Ito S, Kanmatsuse K. Enhanced angiotensin-mediated responses in the nucleus tractus solitarii of spontaneously hypertensive rats. Brain Res Bull. 2003;60:209–214. [PubMed]
  • Laragh JH, Sealey JE, Buhler FR, Vaughan ED, Brunner HR, Gavras H, Baer L. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. Am J Med. 1975;58:4–13. [PubMed]
  • Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Distribution of angiotensin TYPE-I receptor messenger RNA expression in the adult rat brain. Neuroscience. 1998;82:827–841. [PubMed]
  • Li YW, Guyenet PG. Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro. Am J Physiol. 1995;268:R272–R277. [PubMed]
  • Long JA, Evans HM. The oestrous cycle in the rat and its associated phenomena. Univ. California Press; Berkeley, CA: 1922.
  • McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol. 2003;35:901–918. [PubMed]
  • Mendelsohn FA, Allen AM, Clevers J, Denton DA, Tarjan E, McKinley MJ. Localization of angiotensin II receptor binding in rabbit brain by in vitro autoradiography. J Comp Neurol. 1988;270:372–384. [PubMed]
  • Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA. 1984;81:1575–1579. [PubMed]
  • Moulik S, Speth RC, Turner BB, Rowe BP. Angiotensin II receptor subtype distribution in the rabbit brain. Exp Brain Res. 2002;142:275–283. [PubMed]
  • Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol. 1991;260:R977–R984. [PubMed]
  • Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press; Orlando: 1986.
  • Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates - The New Coronal Set. Academic Press; Orlando: 2005.
  • Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J Mol Med. 2008;86:715–722. [PubMed]
  • Rowe BP, Grove KL, Saylor DL, Speth RC. Angiotensin II receptor subtypes in the rat brain. Eur J Pharmacol. 1990;186:339–342. [PubMed]
  • Rowe BP, Saylor DL, Speth RC. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei. Neuroendocrinology. 1992;55:563–573. [PubMed]
  • Sasaki S, Dampney RA. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension. 1990;15:274–283. [PubMed]
  • Song K, Allen AM, Paxinos G, Mendelsohn FAO. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol. 1992;316:467–484. [PubMed]
  • Sun KQ, Ferguson AV. Angiotensin II and glutamate influence area postrema neurons in rat brain slices. Regul Pept. 1996;63:91–98. [PubMed]
  • Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep. 2003;5:262–268. [PubMed]
  • Tagawa T, Dampney RA. AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Hypertension. 1999;34:1301–1307. [PubMed]
  • Tan PS, Potas JR, Killinger S, Horiuchi J, Goodchild AK, Pilowsky PM, Dampney RA. Angiotensin II evokes hypotension and renal sympathoinhibition from a highly restricted region in the nucleus tractus solitarii. Brain Res. 2005;1036:70–76. [PubMed]
  • Taylor EW. The evolution of efferent vagal control of the heart in vertebrates. Cardioscience. 1994;5:173–182. [PubMed]
  • Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol. 2003;139:191–202. [PMC free article] [PubMed]
  • Wang G, Milner TA, Speth RC, Gore AC, Wu D, Iadecola C, Pierce JP. Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1149–R1157. [PubMed]
  • Willette RN, Barcas PP, Krieger AJ, Sapru HN. Vasopressor and depressor areas in the rat medulla. Identification by microinjection of L-glutamate. Neuropharmacology. 1983;22:1071–1079. [PubMed]